ASCRS conference overview for retina specialists
The American Society of Cataract and Refractive Surgery hosted its 2021 ASCRS and ASOA Annual Meeting July 23-27 in Las Vegas, Nevada.
Retina
Study: Dexamethasone intraocular suspension 9% offering high surgeon, patient satisfaction after cataract surgery
Cathleen McCabe, MD, presents results of a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.
Factors to consider in IOP elevations associated with vitreoretinal treatments
Basil Williams, Jr., MD, reports on the association between development of elevated intraocular pressure and numerous commonly performed vitreoretinal treatments.
Real-world experience with dexamethasone intraocular suspension in cataract surgery
Mitchell A. Jackson, MD, presents details of a retrospective review of dexamethasone intraocular suspension 9%, including reduced postoperative inflammation.
Case report: Intermediate uveitis caused by black ink tattoo
Jonathan D. Shader, DO, CPA, presents a case study involving an uncommon cause of posterior-intermediate uveitis: the black ink used to create a tattoo.
IOL & Surgery
Study shows refractive stability of fluid optic IOL
Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.
Surgical updates for Bausch + Lomb
Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.
Technology
Outcomes of LASIK utilising new topography-integrated aberrometer
Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.
Refining surgical procedures with cloud-based analytical software
Mitch Schultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, provide surgeons with the capacity to refine procedures and give patients better outcomes.
Cataract & Refractive
Exploring collagen cross-linking as a treatment for keratoconus
Kathryn M. Hatch, MD, details how collagen CXL is evolving with the goals of reducing complications and actually improving visual acuity.
Micro-bypass stent implant during cataract surgery: lower IOP, fewer medications
Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.
Glaucoma
Active Sentry handpiece stabilizes IOP, anterior chamber during PEA surgery
Hisaharu Suzuki, MD, PhD, provides insight on how a handpiece maintains the anterior chamber stability even when occlusion occurs, suggesting its usefulness for a safe and efficient surgery.
Cornea
CXL effects remain generally stable 10 years post-treatment
Steven Greenstein, MD, reports on results of epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients 10 years after undergoing laser refractive surgery.
Case study: Sebaceous gland carcinoma with no eyelid involvement
Case study looks at a 90-year-old patient with a sebaceous gland carcinoma with corneal and bulbar conjunctival involvement, but the eyelid was spared.
Ophthalmology
Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment
Elizabeth Yeu, MD, shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of TP03 for the treatment of patients diagnosed with Demodex blepharitis.
Risuteganib for DED: Promising treatment with increased TBUT, low staining scores
Eric Donnenfeld, MD, highlights study results exhibiting risuteganib as a potential treatment option for dry eye disease.
Ocular findings reported in case of siblings with LCA
Case study of 2 sisters with Leber’s congenital amaurosis (LCA) analyzes ocular findings, connection.
Related Content: Ophthalmology | Imaging | Retinal Surgery
